France· FR:60311746
ELIGARD 22,5 mg, poudre et solvant pour solution injectable
A medicinal product containing acétate de leuproréline, registered in France by BB FARMA (ITALIE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACÉTATE DE LEUPRORÉLINE
- Manufacturer
- BB FARMA (ITALIE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009490030371 seringue préremplie polycyclooléfine de poudre pré-connectée à 1 seringue préremplie polypropylène de solvant.EUR 246.13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acétate de leuproréline in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectieMedcor Pharmaceuticals B.V.
- IrelandELIGARD 22.5 mg powder and solvent for solution for injectionBModesto B.V.
- FinlandCAMCEVIAccord Healthcare S.L.U.
- United KingdomCamcevi 42mg prolonged-release suspension for injection pre-filled syringesAccord-UK Ltd
- United StatesCAMCEVIAccord BioPharma, Inc.
- SwedenCAMCEVI 21 mg Injektionsvätska, depotsuspensionAccord Healthcare S.L.U.
- GermanyEligardPb Pharma Gmbh
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Eligard Depot, Enantone Monats-Depot
- Belgium · Depo-Eligard
- Bulgaria · Елигард, Лутрат Депо
- Cyprus · Eligard
- Czechia · Eligard, Leptoprol
- Germany · Eligard, Enantone Monats-Depot
- Denmark · Eligard, Leuprorelin Sandoz
- Estonia · Eligard
- Spain · Eligard Semestral, Eligard Trimestral
- Finland · Eligard, Enanton Depot Dual
- United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
- Greece · Deplanda, Elityran
- Croatia · Eligard, Lerin
- Hungary · Eligard, Leuprorelin Pharmacenter
- Ireland · Eligard, Leuprex 3
- Iceland · Camcevi, Eligard
- Italy · Eligard, Enantone
- Liechtenstein · Camcevi
- Lithuania · Eligard
- Luxembourg · Depo-Eligard, Leugon
- Latvia · Eligard, Leptoprol
- Malta · Deplanda
- Netherlands · Eligard, Leuproreline Sandoz
- Norway · Camcevi, Eligard
- Poland · Eligard, Leuprostin
- Portugal · Eligard, Lutrate Depot
- Romania · Eligard, Leptoprol
- Sweden · Eligard, Enanton Depot Dual
- Slovenia · Eligard, Leptoprol
- Slovakia · Eligard, Leuprorelin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbe3375c-6c7d-492d-a1da-39eaafc1b3b1 GET /v1/drugs/fbe3375c-6c7d-492d-a1da-39eaafc1b3b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60311746",
"date_amm": "2024-10-09",
"type_amm": "Autorisation d'importation parallèle",
"numero_ue": null,
"substance": "ACÉTATE DE LEUPRORÉLINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acétate de leuproréline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.